像Wegovy和Zepbound下跌这样的减肥药品的价格,使没有保险的美国人更容易获得这些药品。 Prices for weight loss drugs like Wegovy and Zepbound drop, making them more accessible to uninsured Americans.

Wegovy和Zepbound等减重药物的成本已经下降,因为制药商提供了较低成本的选择。 The cost of weight loss drugs like Wegovy and Zepbound has decreased due to drugmakers offering lower-cost options. 这种价格下跌使那些没有保险或保险范围有限的人更容易获得药品。 This price drop makes the medications more accessible to those without insurance or with limited coverage. 价格下降,从每月400美元到500美元不等,其原因包括公众压力、竞争和通用版本的批准。 The reduced prices, ranging from $400 to $500 a month, come from factors including public pressure, competition, and the approval of generic versions. 保险覆盖面也有所扩大,使患者更能负担得起治疗费用。 Insurance coverage has also expanded, making the treatments more affordable for patients.